INTEGRATED BIOPHARMA INC (INBP) FY2026 Annual Balance Sheet

Income StatementCash FlowBalance Sheet

Balance Sheet

As of 2026-06-30

Swipe to see the full flow
INTEGRATED BIOPHARMA INC (INBP) FY2026 Annual Balance SheetBalance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.Current liabilities$5.80 MLiabilities$7.67 MNon-current liabilities$1.87 MEquity$17.67 MCurrent assets$17.38 MGross equity(calculated)$52.03 MAssets$25.34 MNon-current assets$7.96 MHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSInventoriesCashAccounts receivable (less allowance of credit losses of $20)Other current assetsDeferred tax assets, netOperating lease right-of-use assetsProperty and equipment, netFinance lease right-of-use assetsSecurity deposits and other assetsAccounts payableAccrued expenses and other current liabilitiesOperating Lease, Liability, CurrentCurrent portion of finance lease obligationOperating lease obligationsFinance lease obligationsAdditional paid-in-capitalCommon Stock, $0.002 par value; 50,000,000 shares authorized; 31,094,510 and 31,059,610 shares issued and outstanding, respectivelyCurrent assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Accumulated deficitLess: Treasury stock, at cost, 34,900 sharesCurrent liabilitiesCurrent liabilities$5.80 MAccounts payableAccounts payable$3.20 MAccrued expenses and other current liabilitiesAccrued expenses and other current liabilities$1.39 MLiabilitiesLiabilities$7.67 MOperating Lease, Liability, CurrentOperating Lease, Liability, Current$1.16 MCurrent portion of finance lease obligationCurrent portion of finance lease obligation$48.00 KNon-current liabilitiesNon-current liabilities$1.87 MOperating lease obligationsOperating lease obligations$1.80 MEquityEquity$17.67 MCurrent assetsCurrent assets$17.38 MFinance lease obligationsFinance lease obligations$67.00 KGross equity (calculated)Gross equity(calculated)$52.03 MInventoriesInventories$9.14 MAssetsAssets$25.34 MCashCash$4.47 MAccounts receivable (less allowance of credit losses of $20)Accounts receivable$3.33 MOther current assetsOther current assets$432.00 KDeferred tax assets, netDeferred tax assets, net$3.08 MNon-current assetsNon-current assets$7.96 MOperating lease right-of-use assetsOperating lease right-of-use assets$2.93 MAdditional paid-in-capitalAdditional paid-in-capital$51.97 MProperty and equipment, netProperty and equipment, net$1.75 MFinance lease right-of-use assetsFinance lease right-of-use assets$144.00 KSecurity deposits and other assetsSecurity deposits and other assets$53.00 KCommon Stock, $0.002 par value; 50,000,000 shares authorized; 31,094,510 and 31,059,610 shares issued and outstanding, respectivelyCommon stock$62.00 KAccumulated deficitAccumulated deficit−$34.26 MLess: Treasury stock, at cost, 34,900 sharesLess: Treasury stock, at cost, 34,900 shares−$99.00 K
Chart details

INTEGRATED BIOPHARMA INC (INBP) FY2026 Annual Balance Sheet

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

Assets
25,338,000 US dollars
Current assets
17,379,000 US dollars
Non-current assets
7,959,000 US dollars
Liabilities
7,671,000 US dollars
Current liabilities
5,802,000 US dollars
Non-current liabilities
1,869,000 US dollars
Equity
17,667,000 US dollars
Inventories
9,142,000 US dollars
Cash
4,471,000 US dollars
Accounts receivable (less allowance of credit losses of $20)
3,334,000 US dollars
Other current assets
432,000 US dollars
Deferred tax assets, net
3,079,000 US dollars
Operating lease right-of-use assets
2,929,000 US dollars
Property and equipment, net
1,754,000 US dollars
Finance lease right-of-use assets
144,000 US dollars
Security deposits and other assets
53,000 US dollars
Accounts payable
3,200,000 US dollars
Accrued expenses and other current liabilities
1,393,000 US dollars
Operating Lease, Liability, Current
1,161,000 US dollars
Current portion of finance lease obligation
48,000 US dollars
Operating lease obligations
1,802,000 US dollars
Finance lease obligations
67,000 US dollars
Additional paid-in-capital
51,965,000 US dollars
Common Stock, $0.002 par value; 50,000,000 shares authorized; 31,094,510 and 31,059,610 shares issued and outstanding, respectively
62,000 US dollars
Accumulated deficit
negative 34,261,000 US dollars
Less: Treasury stock, at cost, 34,900 shares
negative 99,000 US dollars
Gross equity (calculated)
52,027,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
INTEGRATED BIOPHARMA INC (INBP) FY2026 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!